Canagliflozin is a medication that is used to treat type 2 diabetes. It is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor that works by blocking the reabsorption of glucose in the kidneys, reducing blood sugar levels and improving glycemic control. Its chemical name is (1S)-1,5-Anhydro-1-C-(3-((4-ethoxyphenyl)methyl)-4-fluorophenyl)-D-glucitol hemihydrate, and its molecular formula is C24H25FO5 • 0.5 H2O, with a formula weight of 444.46 g/mol. The CAS number for this product is 842133-18-0.
Chemical name:
The chemical name for Canagliflozin is (1S)-1,5-Anhydro-1-C-(3-((4-ethoxyphenyl)methyl)-4-fluorophenyl)-D-glucitol hemihydrate.
Molecular formula:
The molecular formula for Canagliflozin is C24H25FO5 • 0.5 H2O.
Formula weight:
The formula weight for Canagliflozin is 444.46 g/mol.
CAS No:
The CAS number for Canagliflozin is 842133-18-0.
Top ten keywords from Google and Synonyms:
Health benefits of this product:
Canagliflozin is primarily used to treat type 2 diabetes. By blocking the reabsorption of glucose in the kidneys, it can reduce blood sugar levels and improve glycemic control. This can help individuals with diabetes better manage their condition and reduce their risk of complications.
Potential effects:
The potential effects of Canagliflozin are largely related to its ability to block the reabsorption of glucose in the kidneys. By reducing blood sugar levels and improving glycemic control, it can help individuals with diabetes manage their condition more effectively and reduce their risk of complications. Additionally, it may also lead to modest weight loss and reductions in cardiovascular risk factors.
Product mechanism:
Canagliflozin is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor that works by blocking the reabsorption of glucose in the kidneys. By preventing the kidneys from reabsorbing glucose, more glucose is excreted in the urine, leading to reductions in blood sugar levels and improvements in glycemic control.
Safety:
Canagliflozin is generally considered safe when used as directed. However, like any medication, it can cause side effects or interact with other medications or medical conditions. It is important to follow all dosing instructions provided by your healthcare provider and to inform them of any medications or medical conditions you may have.
Side effects:
Common side effects of Canagliflozin include genital yeast infections, urinary tract infections, and increased urination. Less common side effects may include kidney problems, low blood pressure, and hypoglycemia. If you experience any adverse symptoms after taking Canagliflozin, be sure to inform your healthcare provider immediately.
Dosing information:
The recommended dose of Canagliflozin varies depending on individual patient factors and the severity of the condition being treated. It is important to follow all dosing instructions provided by your healthcare provider and not to exceed the prescribed dose.
Conclusion:
In conclusion, Canagliflozin is a medication that is used to treat type 2 diabetes. Its chemical name is (1S)-1,5-Anhydro-1-C-(3-((4-ethoxyphenyl)methyl)-4-fluorophenyl)-D-glucitol hemihydrate, and its molecular formula is C24H25FO5 • 0.5 H2O, with a formula weight of 444.46 g/mol. By blocking the reabsorption of glucose in the kidneys, it can reduce blood sugar levels and improve glycemic control, helping individuals with diabetes better manage their condition and reduce their risk of complications. While Canagliflozin is generally considered safe when used as directed, it can cause side effects or interact with other medications or medical conditions. It is important to follow all dosing instructions provided by your healthcare provider and to inform them of any medications or medical conditions you may have
